20 Jul. 2016
WILMINGTON, N.C., (July 20, 2016) – Pharmaceutical Product Development, LLC (PPD) today announced it has won the 2016 OpenText Elite Award for the Most Innovative Project in the Health Sciences Sector. The award, presented at OpenText’s annual Enterprise World conference, recognizes PPD’s use of OpenText in developing electronic trial master files (eTMFs) for use in clinical trials.
“Our clients benefit from our innovative use of portal technology to meet government compliance needs,” said Jay Dixon, senior vice president of global quality and compliance for PPD. “PPD is focused on ensuring that our compliance systems support efficient clinical trial processes to help our clients expedite their research programs to improve patients’ health.”
OpenText recognized PPD for developing a global, standardized process and taxonomy to manage the unstructured data acquired or developed during the conduct of a clinical trial. Based on the industry-standard eTMFs, PPD’s version consists of a detailed folder structure, metadata and user groups that provide consistent structure, access and security across all studies for PPD and clients. A single process is employed globally to ensure consistency of the conduct and content of clinical trials, which routinely consist of more than 60,000 documents.
The OpenText Elite Awards recognize outstanding efforts in deriving business value from innovative and successful software deployments using OpenText Enterprise Information Management solutions. PPD was honored among a global field for demonstrating excellence in innovation and implementation of digital solutions.
PPD is a leading global contract research organization providing comprehensive, integrated drug development, laboratory and lifecycle management services. Our clients and partners include pharmaceutical, biotechnology, medical device, academic and government organizations. With offices in 46 countries and more than 16,000 professionals worldwide, PPD applies innovative technologies, therapeutic expertise and a firm commitment to quality to help clients and partners bend the cost and time curve of drug development to deliver life-changing therapies that improve health.
+1 910 558 6096
+1 910 558 6783